Get the Stockscreener App
2.35
5.38%
0.12
Cardiff Oncology Inc stock is traded at $2.35, with a volume of 628.99K.
It is up +5.38% in the last 24 hours and up +14.08% over the past month.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
See More
Previous Close:
$2.23
Open:
$2.21
24h Volume:
628.99K
Relative Volume:
0.55
Market Cap:
$156.34M
Revenue:
$488.00K
Net Income/Loss:
$-41.44M
P/E Ratio:
-2.5269
EPS:
-0.93
Net Cash Flow:
$-31.47M
1W Performance:
+5.38%
1M Performance:
+14.08%
6M Performance:
-14.23%
1Y Performance:
-24.68%
1-Day Range:
$2.20
$2.36
1-Week Range:
$2.20
$2.38
52-Week Range:
$1.90
$5.6395
Cardiff Oncology Inc Stock (CRDF) Company Profile
Name
Cardiff Oncology Inc
Sector
Industry
Phone
858-952-7570
Address
11055 FLINTKOTE AVENUE, SAN DIEGO, CA
Compare CRDF with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRDF
Cardiff Oncology Inc
|
2.35 | 148.35M | 488.00K | -41.44M | -31.47M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | -52.09M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cardiff Oncology Inc Stock (CRDF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-08-25 | Initiated | Ladenburg Thalmann | Buy |
| Jun-24-25 | Initiated | Jefferies | Hold |
| Sep-06-24 | Initiated | Craig Hallum | Buy |
| Jan-05-22 | Initiated | William Blair | Outperform |
| Dec-08-21 | Initiated | Robert W. Baird | Outperform |
| Aug-09-21 | Resumed | Maxim Group | Buy |
| Oct-22-20 | Initiated | H.C. Wainwright | Buy |
| Oct-08-20 | Initiated | Piper Sandler | Overweight |
View All
Cardiff Oncology Inc Stock (CRDF) Latest News
How to interpret RSI for Cardiff Oncology Inc. stockJuly 2025 Closing Moves & Daily Momentum Trading Reports - newser.com
Tools to monitor Cardiff Oncology Inc. recovery probability2025 Dividend Review & Free High Accuracy Swing Entry Alerts - newser.com
Can Cardiff Oncology Inc. (XE7C) stock stage a strong rebound this quarterWeekly Risk Summary & Proven Capital Preservation Tips - newser.com
What is the fair value of Cardiff Oncology Inc. stock nowJuly 2025 Price Swings & Verified Momentum Stock Watchlist - newser.com
Can Cardiff Oncology Inc. (XE7C) stock sustain breakout momentum2025 Investor Takeaways & Safe Investment Capital Preservation Plans - newser.com
How Cardiff Oncology Inc. stock trades during market volatility2025 Analyst Calls & AI Enhanced Trade Execution Alerts - newser.com
Is Cardiff Oncology Inc. stock a safe investment in uncertain markets2025 Major Catalysts & High Yield Equity Trading Tips - newser.com
How Cardiff Oncology Inc. (XE7C) stock reacts to stronger dollar2025 Macro Impact & Daily Volume Surge Signals - newser.com
Can Cardiff Oncology Inc. hit a new high this monthTrade Entry Report & High Accuracy Trade Alerts - newser.com
What dividend safety score for Cardiff Oncology Inc. stockEarnings Overview Report & Precise Trade Entry Recommendations - newser.com
Cardiff Oncology Inc XE7C Stock Analysis and ForecastSector ETF Performance & Accelerated Financial Growth - earlytimes.in
Will Cardiff Oncology Inc. stock gain from lower inflationPortfolio Return Summary & Weekly Stock Breakout Alerts - newser.com
Should you hold or exit Cardiff Oncology Inc. now2025 Market Outlook & Capital Efficient Trade Techniques - newser.com
Combining price and volume data for Cardiff Oncology Inc.Day Trade & Fast Momentum Entry Tips - newser.com
How Cardiff Oncology Inc. stock reacts to Fed rate cuts2025 Sector Review & Accurate Entry/Exit Alerts - newser.com
What hedge fund activity signals for Cardiff Oncology Inc. stock2025 Price Targets & Expert Curated Trade Setup Alerts - newser.com
Can Cardiff Oncology Inc. (XE7C) stock double in coming yearsPortfolio Gains Summary & Expert Approved Momentum Ideas - newser.com
Will Cardiff Oncology Inc. bounce back from current supportTrade Signal Summary & Low Risk Entry Point Guides - newser.com
Is Cardiff Oncology Inc. forming a reversal patternBond Market & Capital Protection Trading Alerts - newser.com
Cardiff Oncology (CRDF) Projected to Post Earnings on Thursday - MarketBeat
What technical signals suggest for Cardiff Oncology Inc. stockQuarterly Portfolio Report & Verified Momentum Watchlists - newser.com
Cardiff Oncology, Inc. (NASDAQ:CRDF) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
What does recent volatility data suggest for Cardiff Oncology Inc.Quarterly Portfolio Review & Safe Swing Trade Setups - newser.com
Cardiff Oncology Stock Jumped 11% in a Month, What Now? - Trefis
Cardiff Oncology Inc Stock (CRDF) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):